Form D · Pharmaceuticals
Pelthos Therapeutics Inc.
Durham, NC · CIK 0001919246
Offering snapshot reported Nov 19, 2025 · SEC filing
- Reported sold
- $18M Offering amount: $18M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 6, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 19, 2025 | Initial | $18,000,000 | No comparison | 8 | SEC filing |
| Jul 10, 2025 | Initial | $50,100,000 | No comparison | 13 | SEC filing |
| Aug 6, 2024 | Initial | Yet to sell | No comparison | 1 | SEC filing |
| Aug 6, 2024 | Initial | $750,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-564384
Senior secured convertible notes, which are convertible into shares of the Company's common stock, par value $0.0001 per share.
Source: Form D, filed Nov 19, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard Baxter | Director |
| Todd Davis | Director |
| Ezra Friedberg | Director |
| Peter Greenleaf | Director |
| Francis Knuettel | Executive |
| Francis Knuettel Ii | Executive |
| Eric Lang | Executive |
| Richard Malamut | Director |
| Matthew Pauls | Director |
| Scott Plesha | Director, Executive |
| Sai Rangarao | Executive |
| Chia Lin Simmons | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
4020 Stirrup Creek Drive Suite 110
Durham, NC, 27703
Phone: 919-908-2400
Durham, NC, 27703
Phone: 919-908-2400